share_log

HC Wainwright & Co. Maintains Buy on Evofem Biosciences, Raises Price Target to $4

HC Wainwright & Co. Maintains Buy on Evofem Biosciences, Raises Price Target to $4

HC Wainwright & Co.維持對Evofem Biosciences的買入,將目標價上調至4美元
Benzinga Real-time News ·  2022/08/15 06:38

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Evofem Biosciences (OTC:EVFM) with a Buy and raises the price target from $2 to $4.

HC Wainwright&Co.分析師Raghuram Selvaraju維持Evofem Biosciences(場外交易代碼:EVFM)的買入,並將目標價從2美元上調至4美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論